Communiqués Artivion, Inc.

Actions

AORT

US2289031005

Temps réel estimé Cboe BZX Autres places de cotation 17:04:03 10/06/2024			Varia. 5j.	Varia. 1 janv.
23,16 ^USD	-0,77 %		-1,95 %	+29,03 %

07/05	ARTIVION, INC. : Opinion positive de Stifel Nicolaus	ZM
07/05	ARTIVION, INC. : Needham & Co. toujours positif	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Artivion: Q1 Earnings Snapshot	06/05	AQ
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results	22/04	PR
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference	01/04	PR
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference	07/03	AQ
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	06/03	PR
Artivion: Q4 Earnings Snapshot	15/02	AQ
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results	01/02	PR
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting	29/01	PR
Artivion Obtains $350 Million in Senior Secured Credit Facilities	19/01	AQ
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer, Announces Retirement of D. Ashley Lee, Chief Financial Officer	07/12	AQ
Artivion Announces Completion of Enrollment in PERSEVERE Trial	09/11	PR
Artivion to Participate in Upcoming Investor Conferences	08/11	PR
Artivion Reports Third Quarter 2023 Financial Results	03/11	AQ
Artivion: Q3 Earnings Snapshot	02/11	AQ
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results	19/10/23	PR
Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin	06/10/23	AQ
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting	05/10/23	PR
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference	26/09/23	PR
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase	14/09/23	PR
Artivion to Participate in Upcoming Investor Conferences	01/08/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Artivion, Inc.

Actions

AORT

US2289031005

Communiqués

Filtres